Crovalimab Antibody
Crovalimab is an engineered humanized anti-C5 monoclonal antibody that inhibits terminal complement activation by blocking C5 cleavage, thereby preventing MAC formation and intravascular hemolysis. Its pH-dependent FcRn recycling extends its half-life, making it a relevant therapeutic candidate for research in complement-mediated diseases like PNH, supported by in vitro and in vivo studies.
Product Specifications
Product Name Alternative
SKY 59, SKY59, RO7112689, RO 7112689
Target
Complement System
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
25.521 mg/mL
Purity
≥95% (May vary between batches)
Molecular Weight
~150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PA1892-Biotin 100 µg/Vial
Anti-JNK1/MAPK8 Antibody Picoband® (Biotine Conjugate)
Sign In for Pricing
View Details 
MBS7063070 Inquire
Recombinant Magnetococcus sp. Protein CrcB homolog (crcB), partial
Sign In for Pricing
View Details 
OR306042 1 Each
2-[4- (3-Methoxyphenyl) -tetrahydro-2H-pyran-4-yl]acetic acid
Sign In for Pricing
View Details